Evidence map›Paper›PMID 35674491›Full record

ArticleeLife2022

METTL18-mediated histidine methylation of RPL3 modulates translation elongation for proteostasis maintenance.

Eriko Matsuura-Suzuki, Tadahiro Shimazu, Mari Takahashi, Kaoru Kotoshiba, Takehiro Suzuki, Kazuhiro Kashiwagi, Yoshihiro Sohtome, Mai Akakabe, Mikiko Sodeoka, Naoshi Dohmae and 3 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 35 citations in OpenAlex.

  1. METTL18 is Required for Developmental, Metabolic, and Endocrine Regulation of Mammalian Growth.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Built differently or defective: can RNA exosomopathies cause ribosome heterogeneity?Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  13. Article
  14. Article
  15. Review
  16. METTL Family in Healthy and Disease.Molecular biomedicine · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Eriko Matsuura-Suzuki *RNA Systems Biochemistry Laboratory, RIKEN Cluster for Pioneering Research, Saitama, Japan.ORCID 0000-0002-1485-7959
Tadahiro Shimazu *Cellular Memory Laboratory, RIKEN Cluster for Pioneering Research, Saitama, Japan.ORCID 0000-0003-2331-091X
Mari TakahashiLaboratory for Translation Structural Biology, RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan.ORCID 0000-0002-9995-0019
Kaoru KotoshibaCellular Memory Laboratory, RIKEN Cluster for Pioneering Research, Saitama, Japan.
Takehiro SuzukiBiomolecular Characterization Unit, Technology Platform Division, RIKEN Center for Sustainable Resource Science, Saitama, Japan.
Kazuhiro KashiwagiLaboratory for Translation Structural Biology, RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan.ORCID 0000-0001-6470-5817
Yoshihiro SohtomeRIKEN Center for Sustainable Resource Science, Saitama, Japan.ORCID 0000-0002-9165-6720
Mai AkakabeSynthetic Organic Chemistry Lab, RIKEN Cluster for Pioneering Research, Saitama, Japan.
Mikiko SodeokaRIKEN Center for Sustainable Resource Science, Saitama, Japan.ORCID 0000-0002-1344-364X
Naoshi DohmaeBiomolecular Characterization Unit, Technology Platform Division, RIKEN Center for Sustainable Resource Science, Saitama, Japan.ORCID 0000-0002-5242-9410
Takuhiro ItoLaboratory for Translation Structural Biology, RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan.ORCID 0000-0003-3704-5205
Yoichi ShinkaiCellular Memory Laboratory, RIKEN Cluster for Pioneering Research, Saitama, Japan.ORCID 0000-0002-6051-2484
Shintaro IwasakiRNA Systems Biochemistry Laboratory, RIKEN Cluster for Pioneering Research, Saitama, Japan.ORCID 0000-0001-7724-3754
Pioneer (United States) · USRIKEN Center for Biosystems Dynamics Research · JPRIKEN Center for Sustainable Resource Science · JP

Funding

Pacific Biosciences PacBio RS Single Molecule Real Time SequencerS10OD018174 · OD · UNIVERSITY OF CALIFORNIA BERKELEY · PI ROKHSAR, DANIEL SOLEYMAN · 2014 to 2014
$600k
NIH HHS S10 OD018174
6 · The paper itself

Abstract

Protein methylation occurs predominantly on lysine and arginine residues, but histidine also serves as a methylation substrate. However, a limited number of enzymes responsible for this modification have been reported. Moreover, the biological role of histidine methylation has remained poorly understood to date. Here, we report that human METTL18 is a histidine methyltransferase for the ribosomal protein RPL3 and that the modification specifically slows ribosome traversal on Tyr codons, allowing the proper folding of synthesized proteins. By performing an in vitro methylation assay with a methyl donor analog and quantitative mass spectrometry, we found that His245 of RPL3 is methylated at the τ-

Indexed as

HistidineMethyltransferasesProteostasisRibosomal Protein L3HumansMethylationProtein BiosynthesisHistidineMethyltransferasesRibosomal Protein L3RPL3 protein, humanbiochemistrychemical biologychromosomesgene expressionhumanMethylationproteostasisPTMRibosomeRibosome profilingTranslation

Identifiers

PMID35674491
PMCPMC9177149
OpenAlexW4282941964

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.